175 related articles for article (PubMed ID: 38399965)
61. Cellular origin of Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus-induced cell reprogramming.
Cancian L; Hansen A; Boshoff C
Trends Cell Biol; 2013 Sep; 23(9):421-32. PubMed ID: 23685018
[TBL] [Abstract][Full Text] [Related]
62. Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells.
Valiya Veettil M; Krishna G; Roy A; Ghosh A; Dutta D; Kumar B; Chakraborty S; Anju TR; Sharma-Walia N; Chandran B
J Virol; 2020 Mar; 94(8):. PubMed ID: 31969437
[TBL] [Abstract][Full Text] [Related]
63. Variants of Kaposi's sarcoma in Southern Africa. A retrospective analysis (1980-1992).
Stein ME; Lachter J; Spencer D; Margolius L; Bezwoda WR
Acta Oncol; 1996; 35(2):193-9. PubMed ID: 8639315
[TBL] [Abstract][Full Text] [Related]
64. The clinical application of plasma Kaposi sarcoma herpesvirus viral load as a tumour biomarker: results from 704 patients.
Haq IU; Dalla Pria A; Papanastasopoulos P; Stegmann K; Bradshaw D; Nelson M; Bower M
HIV Med; 2016 Jan; 17(1):56-61. PubMed ID: 26111246
[TBL] [Abstract][Full Text] [Related]
65. Reactivation of Kaposi's sarcoma-associated herpesvirus (KSHV) by SARS-CoV-2 in non-hospitalised HIV-infected patients.
Lambarey H; Blumenthal MJ; Chetram A; Joyimbana W; Jennings L; Orrell C; Schäfer G
EBioMedicine; 2024 Feb; 100():104986. PubMed ID: 38306893
[TBL] [Abstract][Full Text] [Related]
66. Seroprevalence of Kaposi's sarcoma-associated herpesvirus in various populations in Cuba.
Kourí V; Eng SM; Rodríguez ME; Resik S; Orraca O; Moore PS; Chang Y
Rev Panam Salud Publica; 2004 May; 15(5):320-5. PubMed ID: 15231079
[TBL] [Abstract][Full Text] [Related]
67. Human Immunodeficiency Virus-Associated Exosomes Promote Kaposi's Sarcoma-Associated Herpesvirus Infection via the Epidermal Growth Factor Receptor.
Chen L; Feng Z; Yuan G; Emerson CC; Stewart PL; Ye F; Jin G
J Virol; 2020 Apr; 94(9):. PubMed ID: 32051269
[TBL] [Abstract][Full Text] [Related]
68. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK.
Letang E; Lewis JJ; Bower M; Mosam A; Borok M; Campbell TB; Naniche D; Newsom-Davis T; Shaik F; Fiorillo S; Miro JM; Schellenberg D; Easterbrook PJ
AIDS; 2013 Jun; 27(10):1603-13. PubMed ID: 23462220
[TBL] [Abstract][Full Text] [Related]
69. Kaposi's Sarcoma (KS)-associated herpesvirus and its role in KS.
Chang Y; Moore PS
Infect Agents Dis; 1996 Oct; 5(4):215-22. PubMed ID: 8884366
[TBL] [Abstract][Full Text] [Related]
70. Epigenetic Landscape of Kaposi's Sarcoma-Associated Herpesvirus Genome in Classic Kaposi's Sarcoma Tissues.
Sun R; Tan X; Wang X; Wang X; Yang L; Robertson ES; Lan K
PLoS Pathog; 2017 Jan; 13(1):e1006167. PubMed ID: 28118409
[TBL] [Abstract][Full Text] [Related]
71. Genotypic analysis of Kaposi's sarcoma-associated herpesvirus from patients with Kaposi's sarcoma in Xinjiang, China.
Ouyang X; Zeng Y; Fu B; Wang X; Chen W; Fang Y; Luo M; Wang L
Viruses; 2014 Nov; 6(12):4800-10. PubMed ID: 25431948
[TBL] [Abstract][Full Text] [Related]
72. Evaluation of the human herpesvirus 8 DNA load in blood and Kaposi's sarcoma skin lesions from AIDS patients on highly active antiretroviral therapy.
Boivin G; Gaudreau A; Routy JP
AIDS; 2000 Sep; 14(13):1907-10. PubMed ID: 10997393
[TBL] [Abstract][Full Text] [Related]
73. Genotypic and clinicopathological characterization of Kaposi's sarcoma-associated herpesvirus infection in Japan.
Kanno T; Sato Y; Nakamura T; Sakamoto K; Sata T; Katano H
J Med Virol; 2010 Mar; 82(3):400-6. PubMed ID: 20087946
[TBL] [Abstract][Full Text] [Related]
74. Prevalence of antibodies against Kaposi's sarcoma associated herpes virus (KSHV) complement inhibitory protein (KCP) in KSHV-related diseases and their correlation with clinical parameters.
Okroj M; Tedeschi R; Mancuso R; Brambilla L; Tourlaki A; Dillner J; Blom AM
Vaccine; 2011 Feb; 29(6):1129-34. PubMed ID: 21134448
[TBL] [Abstract][Full Text] [Related]
75. Similar Immunological Profiles Between African Endemic and Human Immunodeficiency Virus Type 1-Associated Epidemic Kaposi Sarcoma (KS) Patients Reveal the Primary Role of KS-Associated Herpesvirus in KS Pathogenesis.
Lidenge SJ; Tso FY; Ngalamika O; Ngowi JR; Mortazavi Y; Kwon EH; Shea DM; Minhas V; Mwaiselage J; Wood C; West JT
J Infect Dis; 2019 Apr; 219(8):1318-1328. PubMed ID: 30452681
[TBL] [Abstract][Full Text] [Related]
76. HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling.
Yan Q; Shen C; Qin J; Li W; Hu M; Lu H; Qin D; Zhu J; Gao SJ; Lu C
J Virol; 2016 Oct; 90(19):8739-53. PubMed ID: 27440900
[TBL] [Abstract][Full Text] [Related]
77. Prevalence and associated risk factors for Kaposi's sarcoma among HIV-positive patients in a referral hospital in Northern Tanzania: a retrospective hospital-based study.
Semango GP; Charles RM; Swai CI; Mremi A; Amsi P; Sonda T; Shao ER; Mavura DR; Joosten LAB; Sauli E; Nyindo M
BMC Cancer; 2018 Dec; 18(1):1258. PubMed ID: 30558571
[TBL] [Abstract][Full Text] [Related]
78. Kaposi sarcoma-associated herpesvirus, HIV-1 and Kaposi sarcoma risk in black South Africans diagnosed with cancer during antiretroviral treatment rollout.
Motlhale M; Muchengeti M; Bradshaw D; Chen WC; Singini MG; de Villiers CB; Lewis CM; Bender N; Mathew CG; Newton R; Waterboer T; Singh E; Sitas F
Int J Cancer; 2023 May; 152(10):2081-2089. PubMed ID: 36727526
[TBL] [Abstract][Full Text] [Related]
79. Serum HHV8 DNA and Tat antibodies in Kaposi's sarcoma patients with and without HIV-1 infection.
Massambu C; Pyakurel P; Kaaya E; Enbom M; Urassa W; Demirhan I; Loewer J; Linde A; Chandra A; Heiden T; Doerr HW; Chandra P; Biberfeld P
Anticancer Res; 2003; 23(3B):2389-95. PubMed ID: 12894519
[TBL] [Abstract][Full Text] [Related]
80. The Kaposi's Sarcoma-Associated Herpesvirus (KSHV) gH/gL Complex Is the Predominant Neutralizing Antigenic Determinant in KSHV-Infected Individuals.
Mortazavi Y; Lidenge SJ; Tran T; West JT; Wood C; Tso FY
Viruses; 2020 Feb; 12(3):. PubMed ID: 32111001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
